Trump admin Bureau of Prisons issues new policy detransitioning all trans federal prisoners via “tapering plans”; Now being fought in court by ACLU; Trans prisoners testify to retaliation from Trump admin BOP for previously filing declarations in the case, allegations which DOJ has not contested

The gist is

1. tapering plans or immediate cessation of HRT for all trans federal prisoners, even those who are post-op; no HRT for those with newly diagnosed gender dysphoria

2. no social accommodations (clothing, etc.)

3. no surgeries (no surprise there but I’ll mention it anyways)

The plan is now in court and being challenged by the ACLU. Okay here’s the relevant [excerpts](https://www.documentcloud.org/documents/27307934-bop-526001-management-of-inmates-with-gender-dysphoria/):

page 1

> Purpose and scope: To establish professional guidelines for the mental health evaluation and treatment of inmates meeting the diagnostic criteria for Gender Dysphoria **to assist with their progress toward recovery**

page 5-6

> Executive Order 14,168, *Defending Women from Gender Ideology Extremism and Restoring Biological Truth to the Federal Government*, prohibits the Bureau from expending federal funds “for any medical procedure, treatment, or drug for the purpose of conforming an inmate’s appearance to that of the opposite sex” “to the extent consist with applicable law.” The Bureau will comply with this Executive Order unless compliance with the Executive Order is prohibited by a court injuction or court order. Though Executive Order 14,168 supports this policy, the Bureau also adopts this policy independently of Executive Order 14,168.

page 6

> In general, identified medical and psychiatric comorbidities should be addressed before treatment for GD proceeds.

page 7-8

> In instances when an inmate is diagnosed with GD but is not currently receiving hormones to address GD, the Bureau will not provide hormones to address GD and the inmate will not receive hormones to address GD… The individualized treatment plan may include psychotherapy, group counseling, psychiatric services, and psychotropic medications.

> In instances when an inmate is previously and currently diagnosed with GD and is currently receiving hormones to address GD, the MRT shall review and approve or disapprove the tapering plan submitted by the Primacy Care Provider for all such inmates.

> **For inmates that have recently begun receiving hormones to address GD, the Primacy Care Provider shall develop a tapering plan that includes a rapid discontinuation of the hormone intervention.**

> **For inmates that have been receiving hormones to address GD for an extended period of time, the Primary Care Provider shall develop a tapering plan that includes an appropriately paced discontinuation of the hormone intervention.**

> For inmates who (1) are post sex trait modification surgery or (2) have been receiving hormones to address GD for an extended period of time and develop physiological and psychological withdrawal effects from tapering, it may not be appropriate in all cases for the initial tapering plan to include cessation of hormones. **But tapering plans should be reevaluated regularly with respect to cessation of hormones, including during the inmate’s chronic care clinic appointments.**

page 8

> The Bureau will not provide social accommodations, including to inmates diagnosed with GD, and the inmate will not receive social accommodations.

!ping LGBT&BROKEN-WINDOWS&HEALTH-POLICY